Study type

Study topic

Human medicinal product
Disease /health condition

Study type

Non-interventional study

Scope of the study

Drug utilisation

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Prescription event monitoring
Study drug and medical condition

Name of medicine

ELMIRON

Medical condition to be studied

Cystitis interstitial
Off label use
Population studied

Short description of the study population

Adult patients treated with elmiron® suffering from chronic interstitial cystitis

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Chronic interstitial cystitis

Estimated number of subjects

100
Study design details

Main study objective

The objective of this study is to characterise the patients treated with elmiron® and how elmiron® is used (e.g. age, diagnostic criteria for prescription, dosage, duration of treatment, reasons for stopping treatment, and co-treatment). Primary objective = Characterisation of elmiron® treatment practice for the treatment of IC/BPS

Data analysis plan

ELMIRON is a non-comparative, exploratory study not involving the formal testing of any preformulated hypotheses. Parameters are summarised by appr. key figures (number, percentage for categorical data, arithmetic mean, standard deviation, minimum, median, maximum, sample size for metric data). The Kaplan-Meier-Estimator used to model drug survival. Descriptive statistics are performed for all subjects and defined subgroups. The creation of additional subgroups is permissible. Differences between the groups are tested by the non-parametric Mann-Whitney Test and the χ² Test for significance in a purely exploratory fashion. The statistical analysis software Stata® is used for all statistical analyses.